Association of sightseeing tourists and COVID-19 outbreak: A case study of a resort island
キーワード:COVID-19、 airport users、 effective reproduction number、 hotel visitors、 resort island、 sightseeing tourists
Long-distance travel for sightseeing was believed to spread the COVID-19 outbreak. It was banned until 2022. However, details of travel effects on infectivity had never been examined. This study was conducted to assess long-distance travel effects on infectivity at a resort island, including a period when mutated strains were dominant. Unique daily data of Yakushima Airport users and visitors at a major hotel in Yakushima were used to evaluate sightseeing tourism effects on newly confirmed COVID-19 patients. During the study period of August 19, 2020 – August 10, 2022, the Omicron variant strain was dominant. Sightseeing tourists as represented by airport users were found to have no significant effect on infectivity. Hotel visitors might have had a significant positive effect, but the expected magnitude of the effect was one patient, at most. Results suggest that sightseeing tourists did not heavily affect the COVID-19 outbreak.
利益相反に関する開示No author has any conflict of interest, financial or otherwise, to declare in relation to this study.
Anzai A, Nishiura H. “Go To Travel” Campaign and Travel-Associated Coronavirus Disease 2019 Cases: A Descriptive Analysis, July August 2020. J Clin Med. 2021;10: 398.
Kimball A, Hatfield KM, Arons M, James A, Taylor J, Spicer K, et al. Public Health, Seattle & King County; CDC COVID-19 Investigation Team. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility – King County, Washington, March 2020. Morb Mortal Wkly Rep. 2020;69: 377–381.
Kurita J, Sugawara T, Ohkusa Y. Effects of climate conditions, mobility trends, and countermeasures on the COVID-19 outbreak in Japan
Kurita J, Sugawara T, Ohkusa Y. Infectivity of omicron BA.5 comparison with original strain and other mutated strain of SARS-Cov-2 in Japanhttps://jxiv.jst.go.jp/index.php/jxiv/preprint/view/123
Kurita J, Iwasaki Y. Did Visitors for Sightseeing Actually Spread COVID-19 Outbreak dominated the original strain in Japan? Ex Post Evaluation for Banning of Long Distance Travel, https://jxiv.jst.go.jp/index.php/jxiv/preprint/view/226
European Centre for Disease Prevention and Control. Epidemiological update: SARS-CoV-2 Omicron sub-lineages BA.4 and BA.5. https://www.ecdc.europa.eu/en/news-events/epidemiological-update-sars-cov-2-omicron-sub-lineages-ba4-and-ba5 [accessed on August 22, 2022]
National Institute of Infectious Diseases. Updated Situation of COVID-19 Outbreak (July 13,2022) https://www.niid.go.jp/niid/ja/2019-ncov/11309-covid19-ab90th.html (in Japanese) [accessed on August 20, 2022]
The Nippon Communications Foundation, Japan to Suspend Go To Travel Program Entirely Politics Dec 15, 2020 [accessed on November 22,2022] https://www.nippon.com/en/news/yjj2020121400645/japan-to-suspend-go-to-travel-program-entirely.html
Shi P, Dong Y, Yan H, Zhao C, Li X, Liu W, et al. Impact of temperature on the dynamics of the COVID-19 outbreak in China. Sci Total Environ. 2020;728: 138890.
Tobias A, Molina T. Is temperature reducing the transmission of COVID-19? Environ Res. 2020;186: 109553.
Yao Y, Pan J, Liu Z, Meng X, Wang W, Kan H, et al. No association of COVID-19 transmission with temperature or UV radiation in Chinese cities. Eur Respir J. 2020;55: 2000517.
Walrand S. Autumn COVID-19 surge dates in Europe correlated to latitudes, not to temperature-humidity, pointing to vitamin D as contributing factor. Scientific Reports. volume 11, Article number: 1981 (2021) https://www.nature.com/articles/s41598-021-81419-w
Kurita J, Sugawara T, Ohkusa Y. Mobility data can reveal the entire COVID1-19 outbreak course in Japan. MEDRXIV/2020/081315 https://www.medrxiv.org/content/10.1101/2020.04.26.20081315v3
Bergman N, Fishman R. Mobility Reduction and Covid-19 Transmission Rates.doi:
Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 2020;584(7820): 257--261. doi: 10.1038/s41586-020-2405-7.
Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, et al. Usher Network for COVID-19 Evidence Reviews (UNCOVER) group. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. 2021;21: 193--202. DOI:https://doi.org/10.1016/S1473-3099(20)30785-4?
Larrosa JMC. SARS-CoV-2 in Argentina: Lockdown, mobility, and contagion. J Med Virol 2020. doi: 10.1002/jmv.26659.
Kurita J, Sugawara T, Ohkusa Y. Estimating Event Ban Effects on COVID-19 Outbreak in Japan. Journal of Health Science and Development. 2021;4. https://www.innovationinfo.org/articles/JHSD/JHSD-137.pdf
Kurita J. Iwasaki Y. Did visitors for sightseeing actually spread COVID-19 outbreak dominated the omicron variant strain in Japan ? A case study at resort island. https://doi.org/10.51094/jxiv.232
Leung K, Shum MHH, Leung GM, Lam TTY, Wu JT. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Euro. Surveill. 2021;26: 2002106. doi: 10.2807/1560-7917.ES.2020.26.1.2002106.
Graham MS, Sudre CH, May A, Antonelli M, Murray B, Varsavsky T, et al. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. Lancet Public Health. 2021;6: e335-e345.
Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538): eabg3055. doi: 10.1126/science.abg3055.
Zhao S, Lou J, Cao L, Zheng H, Chong MKC, Chen Z, et al. Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis. J. Travel Med. 2021;28: taab011.
Anzai A, Nishiura H. “Go To Travel” Campaign and Travel-Associated Coronavirus Disease 2019 Cases: A Descriptive Analysis, July–August 2020. J. Clin. Med. 2021;10: 398. https://doi.org/10.3390/jcm10030398
Tanegashima and Yakushima Tourism Association. Survey of visitors to Tanegashima and Yakushima. 31 June, 2022 (in Japanese)
Yakushima Town Office. Situation of the COVID-19 infected in Yakushima http://www.town.yakushima.kagoshima.jp/t_yakushima/wp-content/uploads/2022/09/20220919_Infection_status-2.pdf (in Japanese) [accessed on November, 21, 2022].
投稿日時: 2023-02-28 06:07:06 UTC
公開日時: 2023-03-02 00:18:56 UTC
この作品は、Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licenseの下でライセンスされています。